Clinical Trial Update: Paclitaxel/Carboplatin With or Without Cetuximab in CUP [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating paclitaxel/carboplatin with or without cetuximab for cancers of unknown primary (CUP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of Unknown Primary

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cetuximab (cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Heidelberg University | Conditions: Neoplasms, Unknown Primary, Carcinoma | Phase 2 | Status: UNKNOWN